Charles Lee Bennett
Overview
Explore the profile of Charles Lee Bennett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ribeiro T, Colunga-Lozano L, Araujo A, Bennett C, Hozo I, Djulbegovic B
J Clin Epidemiol
. 2022 Jan;
148:193-195.
PMID: 35093531
Objective: To describe effect sizes of single-arm clinical trials that supported AA approvals. Study Design And Setting: We reviewed all the single-arm approvals granted by the FDA-AA pathway between June1992...
2.
3.
Bennett C, Hermanson T
Clin J Am Soc Nephrol
. 2015 Sep;
10(10):1714-5.
PMID: 26416944
No abstract available.
4.
Rao G, Mann J, Shoaibi A, Bennett C, Nahhas G, Sutton S, et al.
Ann Fam Med
. 2014 Mar;
12(2):121-7.
PMID: 24615307
Purpose: Azithromycin use has been associated with increased risk of death among patients at high baseline risk, but not for younger and middle-aged adults. The Food and Drug Administration issued...
5.
Rao G, Mann J, Shoaibi A, Pai S, Bottai M, Sutton S, et al.
J Hypertens
. 2013 Jul;
31(8):1669-75.
PMID: 23822929
Introduction: Angiotensin receptor blockers (ARBs) are commonly used antihypertensive medication with several other additional proven benefits. Recent controversy on association of lung cancer and other solid malignancy with the use...
6.
Rao G, Mann J, Bottai M, Uemura H, Burch J, Bennett C, et al.
J Clin Pharmacol
. 2013 May;
53(7):773-8.
PMID: 23686462
To address concerns regarding increased risk of prostate cancer (PrCA) among angiotensin receptor blocker (ARB) users, we used national retrospective data from the Department of Veterans Affairs (VA) through the...
7.
Qureshi Z, Norris L, Sartor O, McKoy J, Armstrong J, Raisch D, et al.
J Oncol Pract
. 2012 Oct;
8(2):84-90.
PMID: 23077434
Purpose: Counterfeit pharmaceuticals pose risks domestically. Because of their cost, cancer pharmaceuticals are vulnerable. We review findings from a domestic counterfeiting episode involving erythropoietin and outline anticounterfeiting recommendations for policy...